Literature DB >> 6596829

Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy.

K Suzuki, T Takemura, R Okeda, S Hatakeyama.   

Abstract

We investigated cerebral lesions of methotrexate (MTX)-related disseminated necrotizing leukoencephalopathy (DNL) in two autopsy cases of leukemia by the reconstruction technique of the serial sections and thick sections (700-800 microns) stained with silver impregnation to detect the topographic relation between the vascular changes and parenchymal lesions. We revealed the vascular changes, such as fibrinoid degeneration, hyalinized thickening of the vascular wall, dilatation of lumen and stenosis due to swelling of the endothelial cells and exsudation in the wall, particularly prominent in venules and capillaries of venous side in the territory of the superficial medullary veins. There were no remarkable changes in the arteries, except for the moderate endothelial swelling of arteriolar capillaries. The parenchymal lesions were topographically associated with these vascular changes, and the small necrotic foci confluented each other and formed large irregular necrotic foci. We considered that the DNL may be ascribed to dyshoric damage of the veins and capillaries of the venous side and that the mechanism of vascular injury was probably due to the prolonged direct action of intrathecal MTX on the vessels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6596829     DOI: 10.1007/bf00690468

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  25 in total

1.  On tolerance of brain tissue and sensitivity of brain tumours to irradiation.

Authors:  M LINDGREN
Journal:  Acta Radiol Suppl       Date:  1958

2.  [A further contribution to angiodysgenetic necrotizing myelopathy (Foix-Alajouanine disease)].

Authors:  W SCHOLZ; W WECHSLER
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1959

Review 3.  Paraplegia following intrathecal chemotherapy.

Authors:  J H Saiki; S Thompson; F Smith; R Atkinson
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

4.  Necrotizing encephalopathy following intraventricular instillation of methotrexate.

Authors:  W R Shapiro; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1973-02

5.  A primate model for study of methotrexate pharmacokinetics in the central nervous system.

Authors:  D G Poplack; W A Bleyer; J H Wood; M Kostolich; J L Savitch; A K Ommaya
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

Review 6.  Intrathecal methotrexate-induced neurotoxicities.

Authors:  R W Nelson; J T Frank
Journal:  Am J Hosp Pharm       Date:  1981-01

7.  Active transport of methotrexate from cerebrospinal fluid in humans.

Authors:  U Bode; I T Magrath; W A Bleyer; D G Poplack; D L Glaubiger
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

8.  Enhancement of the white matter following prophylactic therapy of the central nervous system for leukemia: radiation effects and methotrexate leukoencephalopathy.

Authors:  P R Shalen; P T Ostrow; P J Glass
Journal:  Radiology       Date:  1981-08       Impact factor: 11.105

9.  The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia.

Authors:  H A Moss; E D Nannis; D G Poplack
Journal:  Am J Med       Date:  1981-07       Impact factor: 4.965

10.  Leukoencephalopathy in childhood leukemia.

Authors:  D C Devivo; D Malas; J S Nelson; V J Land
Journal:  Neurology       Date:  1977-07       Impact factor: 9.910

View more
  5 in total

1.  Disseminated necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia.

Authors:  Ajaya R Pande; Kumiko Ando; Reiichi Ishikura; Yuki Nagami; Masayo Ogawa; Norihiko Kamikonya; Yumi Kaneda; Takakuni Tanizawa; Norio Nakao
Journal:  Radiat Med       Date:  2006-08

2.  MRI in methotrexate-related leukoencephalopathy: Disseminated necrotising leukoencephalopathy in comparison with mild leukoencephalopathy.

Authors:  M Oka; S Terae; R Kobayashi; Y Sawamura; K Kudoh; K K Tha; M Yoshida; M Kaneda; Y Suzuki; K Miyasaka
Journal:  Neuroradiology       Date:  2003-05-22       Impact factor: 2.804

3.  Experimental study on subacute neurotoxicity of methotrexate in cats.

Authors:  M Shibutani; R Okeda
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.

Authors:  W Boogerd; J J vd Sande; D Moffie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

Review 5.  Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features.

Authors:  Hamza Tariq; Andrea Gilbert; Francis E Sharkey
Journal:  Clin Med Insights Pathol       Date:  2018-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.